NICE guidance on ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia in the presence of 17p deletion or TP53 mutation.
作者信息
Mikudina Boglarka, Goodall Melinda, Adler Amanda I
机构信息
National Institute for Health and Care Excellence, London SW1A 2BU, UK.
National Institute for Health and Care Excellence, London SW1A 2BU, UK.
出版信息
Lancet Oncol. 2017 Mar;18(3):289-290. doi: 10.1016/S1470-2045(17)30062-1. Epub 2017 Jan 25.
Abstract
摘要
Zotero 插件